29 Sep

Health ministry releases pharmacovigilance guidelines to ensure ease of doing PV practices

In order to ensure ease of doing pharmacovigilance (PV) practices by the industry, the Union health ministry has finally come out with PV guidelines for Market Authorisation Holders (MAHs) after due deliberations with the stakeholders. Post-release, market authorisation holders will be given six months time to implement the guidelines. Apart from facilitating harmonisation in adverse […]

22 Sep

Health ministry sensitizes pharma cos to set up PV cells for monitoring ADRs

Friday, September 22, 2017, 08:00 Hrs  [IST] In order to equip and sensitise Indian pharma companies to set up pharmacovigilance (PV) cells for generating adverse drug reaction (ADR) data, Ghaziabad based Indian Pharmacopoeia Commission (IPC) under the Union health ministry conducted workshops in Bengaluru and Hyderabad in the first week of September 2017 to help companies […]

Show Buttons
Hide Buttons